69
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Synthesis of Novel Pyrazolyl and Isoxazolyl 3-(Furan-2-yl)-5-Methyl-1-(4-Nitrophenyl)-1H-Pyrazol-4-yl Derivatives via Regioselectivity of the 1,3-Dipolar Cycloaddition

, ORCID Icon, , &
Pages 2212-2225 | Received 28 Feb 2023, Accepted 07 May 2023, Published online: 21 May 2023

References

  • C. Cimarelli, and G. Palmieri, “Total and Semi-Synthetic Approaches to Taxol. Tetrahedron Symposia-in-Print,” Journal of the Chemical Society, Perkin Transactions 1 102 (1996).
  • G. Bartoli, C. Cimarelli, E. Marcantoni, G. Palmieri, and M. Petrini. “Chemo-and Diastereoselective Reduction of P-Enamino Esters: A Convenient Synthesis of Both Cis-and Trans-y-Amino Alcohols and P-Amino Esters Et-0,” Journal of the Chemical Society, Perkin Transactions 1 59 (1994).
  • L.G. Beholz, P. Benovsky, D.L. Ward, N.S. Barta, and J.R. Stille, Formation of Dihydropyridone-and Pyridone-Based Peptide Analogs through Aza-Annulation of-Enamino Ester and Amide Substrates with r-Amido Acrylate Derivatives (1997).
  • Z.N. Siddiqui, “Bis[(L)prolinato-N,O]Zn-Water: A Green Catalytic System for the Synthesis of 3,4-Dihydropyrimidin-2 (1H)-Ones via the Biginelli Reaction,” Comptes Rendus Chimie 16, no. 2 (2013): 183–8. doi:10.1016/j.crci.2012.10.008
  • B.A.D. Neto, A.A.M. Lapis, A.B. Bernd, and D. Russowsky, “Studies on the Eschenmoser Coupling Reaction and Insights on Its Mechanism. Application in the Synthesis of Norallosedamine and Other Alkaloids,” Tetrahedron 65, no. 12 (2009): 2484–96. doi:10.1016/j.tet.2009.01.081
  • O. David, J. Blot, C. Bellec, M.C. Fargeau-Bellassoued, G. Haviari, J.P. Célérier, G. Lhommet, J.C. Gramain, and D. Gardette, “Enamino Ester Reduction: A Short Enantioselective Route to Pyrrolizidine and Indolizidine Alkaloids. Synthesis of (+)-Laburnine, (+)-Tashiromine, and (−)-Isoretronecanol,” The Journal of Organic Chemistry 64, no. 9 (1999): 3122–31. doi:10.1021/jo982169p
  • J.A. Makawana, M.P. Patel, and R.G. Patel, “Synthesis and In Vitro Antimicrobial Activity of N-Arylquinoline Derivatives Bearing 2-Morpholinoquinoline Moiety,” Chinese Chemical Letters 23, no. 4 (2012): 427–30. doi:10.1016/j.cclet.2012.01.017
  • J.E. Foster, J.M. Nicholson, R. Butcher, J.P. Stables, I.O. Edafiogho, A.M. Goodwin, M.C. Henson, C.A. Smith, and K.R. Scott, “Synthesis, Characterization and Anticonvulsant Activity of Enaminones. Part 6: Synthesis of Substituted Vinylic Benzamides as Potential Anticonvulsants,” Bioorganic & Medicinal Chemistry 7, no. 11 (1999): 2415–25. doi:10.1016/s0968-0896(99)00185-6
  • N.D. Eddington, D.S. Cox, R.R. Roberts, J.P. Stables, C.B. Powell, and K.R. Scott, “Enaminones-Versatile Therapeutic Pharmacophores. Further Advances,” Current Medicinal Chemistry 7, no. 4 (2000): 417–36. doi:10.2174/0929867003375092
  • K.R. Scott, Gary O. Rankin, James P. Stables, Mariano S. Alexander, Ivan O. Edafiogho, Vida A. Farrar, Kymberle R. Kolen, Jacqueline A. Moore, Lyndia D. Sims, and Ahn D. Tonnu, “Synthesis and Anticonvulsant Activity of Enaminones. 3. Investigations on 4′-, 3′-, and 2′-Substituted and Polysubstituted Anilino Compounds, Sodium Channel Binding Studies, and Toxicity Evaluations1p2,” Journal of Medicinal Chemistry 38, no. 20 (1995): 4033–43. doi:10.1021/jm00020a019
  • I.O. Edafiogho, K.V.V. Ananthalakshmi, and S.B. Kombian, “Anticonvulsant Evaluation and Mechanism of Action of Benzylamino Enaminones,” Bioorganic & Medicinal Chemistry 14, no. 15 (2006): 5266–72. doi:10.1016/j.bmc.2006.03.049
  • K.V.V. Ananthalakshmi, I.O. Edafiogho, and S.B. Kombian, “Concentration-Dependent Effects of Anticonvulsant Enaminone Methyl 4-(4′-Bromophenyl)Aminocyclohex-3-en-6-Methyl-2-Oxo-1-Oate on Neuronal Excitability In Vitro,” Neuroscience 141, no. 1 (2006): 345–56. doi:10.1016/j.neuroscience.2006.03.021
  • D. Simoni, M. Rizzi, R. Rondanin, R. Baruchello, P. Marchetti, F.P. Invidiata, M. Labbozzetta, P. Poma, V. Carina, M. Notarbartolo, et al., “Antitumor Effects of Curcumin and Structurally β-Diketone Modified Analogs on Multidrug Resistant Cancer Cells,” Bioorganic & Medicinal Chemistry Letters 18, no. 2 (2008): 845–9. doi:10.1016/j.bmcl.2007.11.021
  • H.M. Hassaneen, A.S. Shawali, T.A. Abdallah, and F.M. Saleh, “Synthesis and Cycloaddition Reactions of 4,4-Dimethyl-2,6-Dioxocyclohexane-Thiocarboxamides with Nitrilimines,” General Papers Arkivoc (2014): 155–69. doi:10.3998/ark.5550190.p008.855
  • H.M. Hassaneen, and A.S. Shawali, “Regioselective Synthesis of Some Functionalized 3,4′-Bis-(Pyrazolyl)Ketones and Chemoselectivity in Their Reaction with Hydrazine Hydrate,” European Journal of Chemistry 4, no. 2 (2013): 102–9. doi:10.5155/eurjchem.4.2.102-109.723
  • P. Lue, and J.V. Greenhill, “Enaminones in Heterocyclic Synthesis,” Advances in Heterocyclic Chemistry 67 (1997): 209–344.
  • M.V. Patel, R. Bell, S. Majest, R. Henry, and T. Kolasa, “Synthesis of 4,5-Diaryl-1H-Pyrazole-3-ol Derivatives as Potential COX-2 Inhibitors,” The Journal of Organic Chemistry 69, no. 21 (2004): 7058–65. doi:10.1021/jo049264k
  • M.A.M. Teleb, F.M. Sroor, H.M. Hassaneen, and F.M. Saleh, “Synthesis of Novel Hydrazonoyl Chlorides as Useful Precursor in Synthesis of New Thiadiazoles, Selenadiazoles and Triazolotriazines,” Egyptian Journal of Chemistry 65 (13B) (2022): 1045–1052. doi:10.21608/ejchem.2022.172184.7138
  • M.G. Kamel, F.M. Sroor, A.M. Othman, K.F. Mahrous, F.M. Saleh, H.M. Hassaneen, T.A. Abdallah, I.A. Abdelhamid, and M.A.M. Teleb, “Structure-Based Design of Novel Pyrazolyl–Chalcones as Anti-Cancer and Antimicrobial Agents: Synthesis and In Vitro Studies,” Monatshefte Für Chemie-Chemical Monthly 153, no. 2 (2022): 211–21. doi:10.1007/s00706-021-02886-5
  • M.G. Kamel, F.M. Sroor, A.M. Othman, H.M. Hassaneen, T.A. Abdallah, F.M. Saleh, and M.A.M. Teleb, “Synthesis and Biological Evaluation of New 1,3,4-Thiadiazole Derivatives as Potent Antimicrobial Agents,” Monatshefte Für Chemie-Chemical Monthly 153, no. 10 (2022): 929–37. doi:10.1007/s00706-022-02967-z
  • E.M. Fathi, F.M. Sroor, K.F. Mahrous, M.F. Mohamed, K. Mahmoud, M. Emara, A.H.M. Elwahy, and I.A. Abdelhamid, “Design, Synthesis, In Silico and In Vitro Anticancer Activity of Novel Bis-Furanyl-Chalcone Derivatives Linked through Alkyl Spacers,” ChemistrySelect 6, no. 24 (2021): 6202–11. doi:10.1002/slct.202100884
  • M.F. Mohamed, F.M. Sroor, N.S. Ibrahim, G.S. Salem, H.H. El-Sayed, M.M. Mahmoud, M.A.M. Wagdy, A.M. Ahmed, A.A.T. Mahmoud, S.S. Ibrahim, et al., “Novel [l,2,4]Triazolo[3,4-a]Isoquinoline Chalcones as New Chemotherapeutic Agents: Block IAP Tyrosine Kinase Domain and Induce Both Intrinsic and Extrinsic Pathways of Apoptosis,” Investigational New Drugs 39, no. 1 (2021): 98–110. doi:10.1007/s10637-020-00987-2
  • F.M. Sroor, M.F. Mohamed, G.K. Abdullah, K.F. Mahrous, K.M.A. Zoheir, S.A. Ibrahim, A.H.M. Elwahy, and I.A. Abdelhamid, “Anticancer Activity of New Bis-(3-(Thiophen-2-yl)-1H-Pyrazol-4-yl)Chalcones: Synthesis, In-Silico, and In-Vitro Studies,” Polycyclic Aromatic Compounds 43, no 3 (2022): 2506-23. doi:10.1080/10406638.2022.2046616
  • M.F. Mohamed, F.M. Sroor, S.E. Elsayed, K.F. Mahrous, L. Mageed, M.K. Hanafy, S.A. Ibrahim, A.H.M. Elwahy, and I.A. Abdelhamid, “Synthesis and Anticancer Activities of Novel Bis-Chalcones Incorporating the 1,3-Diphenyl-1H-Pyrazole Moiety: In Silico and In Vitro Studies,” Letters in Drug Design & Discovery 19, no. 11 (2022): 1007–21. doi:10.2174/1570180819666220301151631
  • S.A.F. Rostom, M.A. Shalaby, and M.A. El-Demellawy, “Polysubstituted Pyrazoles, Part 5.1. Synthesis of New 1-(4-Chlorophenyl)-4-Hydroxy-1H-Pyrazole-3-Carboxylic Acid Hydrazide Analogs and Some Derived Ring Systems. A Novel Class of Potential Antitumor and Anti-HCV Agents,” European Journal of Medicinal Chemistry 38, no. 11–12 (2003): 959–74. doi:10.1016/j.ejmech.2003.08.003
  • N.D. Amnerkar, and K.P. Bhusari, “Synthesis, Anticonvulsant Activity and 3D-QSAR Study of Some Prop-2-Eneamido and 1-Acetyl-Pyrazolin Derivatives of Aminobenzothiazole,” European Journal of Medicinal Chemistry 45, no. 1 (2010): 149–59. doi:10.1016/j.ejmech.2009.09.037
  • P.K. Sharma, S. Kumar, P. Kumar, P. Kaushik, D. Kaushik, Y. Dhingra, and K.R. Aneja, “Synthesis and Biological Evaluation of Some Pyrazolylpyrazolines as Anti-Inflammatory-Antimicrobial Agents,” European Journal of Medicinal Chemistry 45, no. 6 (2010): 2650–5. doi:10.1016/j.ejmech.2010.01.059
  • A.M. Farag, A.S. Mayhoub, S.E. Barakat, and A.H. Bayomi, “Regioselective Synthesis and Antitumor Screening of Some Novel N-Phenylpyrazole Derivatives,” Bioorganic & Medicinal Chemistry 16, no. 2 (2008): 881–9. doi:10.1016/j.bmc.2007.10.015
  • Z. Özdemir, H.B. Kandilci, B. Gümüşel, Ü. Çaliş, and A.A. Bilgin, “Synthesis and Studies on Antidepressant and Anticonvulsant Activities of Some 3-(2-Furyl)-Pyrazoline Derivatives,” European Journal of Medicinal Chemistry 42, no. 3 (2007): 373–9. doi:10.1016/j.ejmech.2006.09.006
  • H.M. Hassaneen, A.S. Shawali, N.M. Elwan, and A.H.A. Ibrahim, “Synthesis of C-(2-Furyl)-N-(4-Nitrophenyl)Methanohydrazonyl Bromide. Reactions with Nucleophiles and Active Methylene Compounds,” Archives of Pharmacal Research 14, no. 3 (1991): 266–70. doi:10.1007/BF02876867
  • M.T. Helmy, F.M. Sroor, K.F. Mahrous, K. Mahmoud, H.M. Hassaneen, F.M. Saleh, I.A. Abdelhamid, and M.A. Mohamed Teleb, “Anticancer Activity of Novel 3-(Furan-2-yl)Pyrazolyl and 3-(Thiophen-2-yl)Pyrazolyl Hybrid Chalcones: Synthesis and In Vitro Studies,” Archiv Der Pharmazie 355, no. 3 (2022): 2100381. doi:10.1002/ardp.202100381
  • M.T. Helmy, F.M. Sroor, A.M. Othman, H.M. Hassaneen, F.M. Saleh, and M.A.M. Teleb, “Design, Synthesis and In-Vitro Evaluation of New Furan-Substituted Thiadiazolyl Hydrazone Derivatives as Promising Antimicrobial Agents,” Journal of Heterocyclic Chemistry 60, (2023) 585–595. doi:10.1002/jhet.4611
  • R. Fusco, and P. Dalla, “Synthesis of Hydrazonoyl Halides,” Gazzetta Chimica Italiana 101 (1971): 703.
  • F.A.K. Amer, M. Hammouda, A.A.S. El-Ahl, and B.F. Abdel-Wahab, “Synthesis of Important New Pyrrolo[3,4-c]Pyrazoles and Pyrazolyl-Pyrrolines from Heterocyclic β-Ketonitriles,” Journal of the Chinese Chemical Society 54, no. 6 (2007): 1543–52. doi:10.1002/jccs.200700217
  • E.S. Komarova, V.A. Makarov, L.M. Alekseeva, G.V. Avramenko, and V.G. Granik, “Synthesis of Derivatives of a New Heterocyclic System Pyrazolo[3,44b]Pyrido[1′,2′:1,2]Imidazo[4,55d]Pyridine,” Izvestiya Akademii Nauk. Seriya Khimicheskaya 55 (2006).
  • X. Rao, Z. Song, and L. He, “Synthesis and Antitumor Activity of Novel α-Aminophosphonates from Diterpenic Dehydroabietylamine Xiaoping,” Heteroatom Chemistry 19 (2008): 21–7.
  • N.F. Eweiss, and A. Osman, “Synthesis of Heterocycles. Part II. New Routes to Acetylthiadiazolines and Alkylazothiazoles,” Journal of Heterocyclic Chemistry 17, no. 8 (1980): 1713–7. doi:10.1002/jhet.5570170814
  • A.S. Shawali, and A.O. Abdelhamid, “Reaction of Dimethylphenacylsulfonium Bromide with N -Nitrosoacetarylamides and Reactions of the Products with Nucleophiles,” Bulletin of the Chemical Society of Japan 49, no. 1 (1976): 321–4. doi:10.1246/bcsj.49.321
  • A.M. Farag, and M.S. Algharib, “Synthesis and Reactions of C-(2-Thenoyl)-N-Arylformhydrazidoyl Bromides,” Organic Preparations and Procedures International 20, no. 5 (1988): 521–6. doi:10.1080/00304948809356298

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.